Zobrazeno 1 - 8
of 8
pro vyhledávání: '"T R SanGiacomo"'
Publikováno v:
Journal of Lipid Research, Vol 23, Iss 8, Pp 1224-1235 (1982)
Clinical symptoms, lipoprotein patterns, and apoE phenotypes were determined in 17 individuals with type III hyperlipoproteinemia (type III HLP) and in their relatives and spouses. The apoE phenotype E2/2 occurred in 15 type III HLP probands (88%) an
Externí odkaz:
https://doaj.org/article/0eb66cbcfb2f4629967a28b52ac66057
Autor:
T R, SanGiacomo
Publikováno v:
Rhode Island dental journal. 23(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::720136887198319f4d56c02754361624
https://pubmed.ncbi.nlm.nih.gov/2077632
https://pubmed.ncbi.nlm.nih.gov/2077632
Autor:
T R, SanGiacomo
Publikováno v:
Rhode Island dental journal. 23(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9fdf9c0d5efcdd9ef834746acc054cc9
https://pubmed.ncbi.nlm.nih.gov/2284560
https://pubmed.ncbi.nlm.nih.gov/2284560
Publikováno v:
Biochemistry. 20(25)
Two newly described human hepatoma derived cell lines, Hep G2 and Hep 3B [Knowles, B. B., Howe, C. C., & Aden, D. P. (1980) Science (Washington, D.C.) 209, 497-499], synthesize and secrete into the culture medium most of the major plasma apoproteins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::258dde9de7b16dd0b9d2ab2231890b6c
https://pubmed.ncbi.nlm.nih.gov/6274388
https://pubmed.ncbi.nlm.nih.gov/6274388
Publikováno v:
Clinical Genetics; Oct1988, Vol. 34 Issue 4, p246-251, 6p
Autor:
Jane L.H.C. Third, Jan L. Breslow, Trent Tracy, Charles J. Glueck, Vassilis I. Zannis, Thomas R. SanGiacomo
Publikováno v:
Scopus-Elsevier
Journal of Lipid Research, Vol 23, Iss 8, Pp 1224-1235 (1982)
Journal of Lipid Research, Vol 23, Iss 8, Pp 1224-1235 (1982)
Clinical symptoms, lipoprotein patterns, and apoE phenotypes were determined in 17 individuals with type III hyperlipoproteinemia (type III HLP) and in their relatives and spouses. The apoE phenotype E2/2 occurred in 15 type III HLP probands (88%) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e189b9bbdb430dc60a52d8cb586959b
http://www.scopus.com/inward/record.url?eid=2-s2.0-0020355825&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0020355825&partnerID=MN8TOARS
Autor:
David Kritchevsky
The Proceedings of the Eight International Symposium on Drugs Affecting Lipid Metabolism (8th D.A.L.M.) is the subject of this volume. Since the first symposium in 1960, each successive meeting has broken new ground in the field of pharmacological co
Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2.
Publikováno v:
Journal of lipid research [J Lipid Res] 1982 Nov; Vol. 23 (8), pp. 1224-35.